New role discovered for breast cancer susceptibility gene BRCA1

	Tweet

A recently discovered facet of the breast cancer susceptibility gene BRCA1 reveals a mechanism linking mutation of BRCA1 to formation of large blood vessels needed to support cancer progression.

The findings demonstrate that, in addition to an impaired DNA damage response associated with cancer initiation, mutation of BRCA1 is also linked to manipulation of the tumor microenvironment. The research appears in the July issue of Cancer Cell, published by Cell Press.

Mutations in the breast cancer susceptibility gene BRCA1 account for up to 50% of hereditary breast cancers. BRCA1 is known to serve as a tumor suppressor by regulating DNA damage repair and maintaining genomic stability. Although the mechanism is not fully understood, reduced BRCA1 expression is also often correlated with accelerated growth and progression of breast tumors and with increased tumor blood vessel formation. In order to better understand the link between BRCA1 and tumor progression, Dr. Wen-Hwa Lee and colleagues from the Department of Biological Chemistry at the University of California, Irvine, designed a series of experiments to search for genes that are regulated by BRCA1.

The researchers used microarray analyses to identify genes repressed by BRCA1 or a related tumor suppressor, CtIP, in mammary epithelial cells (MECs). Among the 12 genes inhibited by BRCA1 or CtIP was the gene for a secreted factor, called ANG1, that enhances blood vessel growth and maturation. The researchers found that a defect in a repressor complex formed by BRCA1, CtIP, and another known transcription repressor, ZBRK1, released the gene for ANG1 from repression and promoted survival of neighboring blood vessel cells and formation of capillary-like structures. Further studies demonstrated that mouse mammary tumors deficient in BRCA1 display high levels of ANG1 expression, prominent vascularization, and accelerated growth.

“Our study finds that BRCA1 possesses a role in tumor suppression beyond maintaining genomic stability by regulating intercellular signaling within the tissue microenvironment. This view will extend BRCA1’s tumor suppression function to the surroundings that influence the fate of neighboring cells and fortify the pathogenic relevance of its defect to neoplastic growth,” concludes Dr. Lee.

http://www.cancercell.org/

RELATED STORIES:
Study Finds Two Genes Predict Outcome for Breast Cancer Patients   Researchers identify a new breast and ovarian cancer susceptibility gene   Link Found Between Vegetables and Decreased Risk of Breast Cancer   Gene explains breast cancer chemotherapy outcomes   Breast cancer survivors face other cancer risks   Vitamin A derivative provides clues to better breast cancer drugs   Colour sensor breath test can detect lung cancer   UK agency nearer backing new breast cancer drugs   Certain Breast Cancer Patients May Nix Node Surgery   Study Finds Lapatinib Shows Promise as Therapy for Inflammatory Breast Cancer   Researchers discover new way to ‘rescue’ treatment sensitivity of breast cancer cells   Breast-Sparing Surgery Means More Procedures   Breast Cancer Rates Decline Most for Affluent White Women   The National Breast and Cervical Cancer Early Detection Program Recommendations   Avastin helps breast cancer patients: study   Urine test may tell of breast cancer’s spread   Breast cancer vaccine helps body fight tumors   “Room for improvement” in care after breast cancer   FDA revokes approval of Avastin for breast cancer   MRI ‘best’ for looking at breast cancer and more   Integrating genetic information with breast cancer risk factors may help refine prognosis   Climb to Fight Breast Cancer Offers Peaks for Every Skill Level

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]